Format

Send to

Choose Destination
Psychiatr Clin North Am. 2000 Sep;23(3):643-56.

Pharmacotherapy for obsessive-compulsive disorder.

Author information

1
Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA. eric.hollander@mssm.edu

Abstract

SSRIs and the tricyclic antidepressant clomipramine are the first-line therapies for patients with OCD, with the side-effect profile of SSRIs being more favorable than that of clomipramine. As many as 40% to 60% of patients with OCD may not respond to adequate trials of SRIs. Not all patients tolerate SSRIs, and delays in full therapeutic responses often occur. Thus, other pharmacologic approaches to treating patients with OCD have been investigated. Augmentation and monotherapy have been explored with serotonergic enhancers, dopamine and 5-HT antagonists, enhancers of second-messenger systems, and GABAergic agents with varying efficacy.

PMID:
10986733
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center